InvestorsHub Logo
Followers 11
Posts 1455
Boards Moderated 0
Alias Born 02/01/2013

Re: None

Thursday, 02/21/2019 1:53:54 PM

Thursday, February 21, 2019 1:53:54 PM

Post# of 10487
Just in case anyone missed the implications of adding Ms Beaver to the BOD.
It looks evident the BOD is getting their ducks lined up for Organovo to get acquired.

On February 19, 2019, the Board of Directors (the "Board") of Organovo Holdings, Inc. ( ONVO ) (the "Company") authorized and approved an increase in the size of the Board from eight (8) to nine (9) members and appointed Carolyn Beaver to the Board as Class I Director.

Ms. Beaver has over 30 years of audit and financial management experience. She previously held several positions at Sequenom Inc., a life sciences testing company, including Chief Financial Officer and Senior Vice President from March 2015 to October 2016, Chief Financial Officer from June 2014 to March 2015 and Vice President and Chief Accounting Officer from June 2012 to March 2015. (see below about Sequenom)

Ms. Beaver was previously Corporate Vice President and Controller of Beckman Coulter, Inc., a biomedical laboratory instrument and test company, from August 2005 until June 2012, and was named Chief Accounting Officer in October 2005, a position she held until July 2011, following the acquisition of Beckman Coulter, Inc. by Danaher Corporation.

Ms. Beaver was a director of Commerce National Bank, chair of its audit committee and a member of its asset/liability committee from 2005 until the bank was acquired in 2013.

LabCorp Completes Sequenom Acquisition
Sep 07, 2016
NEW YORK (GenomeWeb) – Laboratory Corporation of America announced today that it has completed its acquisition of Sequenom.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONVO News